Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New Alzheimer's disease model links beta-amyloid amyloidosis and tau pathology

Nov. 6, 2015

Calcipotriol formulation has promising effects in patients with nail psoriasis

Nov. 6, 2015

Conjugation with guanidinoglycosides allow intranasal protein delivery for CNS targeting

Nov. 6, 2015

Gene silencing oligonucleotides target microRNAs to treat atherosclerosis

Nov. 6, 2015

Volanesorsen lowers triglycerides in patients with familial chylomicronemia syndrome

Nov. 6, 2015

Tocopherol-conjugated DNA/RNA heteroduplex oligonucleotides enhance brain and liver targeting

Nov. 5, 2015

OliX Pharmaceuticals discloses its cell-penetrating asymmetric siRNA technology

Nov. 5, 2015

Advances in siRNA therapeutic technology

Nov. 5, 2015

CJ Healthcare presents GPR40 agonists

Nov. 5, 2015

AS-002 shows preventative and curative effect in UC

Nov. 5, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...